HeartSciences Inc.
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.63 | $0 | -$3.4B |
| 2025 Q2 | -0.85 | $2,419 | -$2M |
| 2025 Q1 | -1.58 | $1,900 | -$2M |
| 2025 Q4 | -1.88 | $4,350 | -$2M |
| 2025 Q3 | -2.57 | $0 | -$2M |
| 2024 Q2 | -2.27 | $0 | -$2M |
| 2024 Q1 | -2.64 | $0 | -$2M |
| 2024 Q4 | -2.73 | $0 | -$2M |